Revenue & EPS GrowthSustained double-digit revenue and EPS growth demonstrates durable demand expansion and improving unit economics. Over a multi-quarter horizon this supports reinvestment capacity, scale benefits, and stronger bargaining power with suppliers and customers, underpinning longer-term profit potential.

Healthy MarginsConsistently healthy gross margins and improving net margins indicate effective cost management and pricing discipline. These margin foundations support durable profitability even if revenue growth moderates, enabling the company to fund R&D/capex and maintain competitive positioning over the next several quarters.

Prudent Leverage & ROEA sound balance sheet with moderate leverage and rising ROE signals disciplined capital allocation and financial flexibility. This structure supports strategic investments, withstands industry cyclicality, and reduces refinancing risk, sustaining the firm's ability to pursue growth initiatives long term.

Bears Say

Capex Pressures On FCFElevated capex is materially reducing free-cash-flow conversion despite strong operating cash generation. Over a multi-quarter horizon this can constrain balance sheet flexibility, limit return of capital or deleveraging, and increase dependency on external funding if capex needs persist.

EBIT Margin VolatilityInstability in EBIT margins points to variability in operating efficiency or cost absorption. Persistent margin volatility undermines predictable cash flow and makes capital planning harder, exposing earnings to raw material, pricing, or execution swings over the coming quarters.

Moderate Liability RelianceAlthough overall leverage is described as prudent, the noted reliance on liabilities indicates less cushion than a fully equity-heavy structure. In an adverse cycle or rising rates, this reliance can amplify refinancing and liquidity risk, constraining strategic options over time.

Medico Remedies Ltd. News

Medico Remedies Announces 31st AGM Details

Medico Remedies Ltd. ( ($IN:MEDICO) ) has provided an update. Medico Remedies Limited has announced the completion of...

7M ago

MEDICO FAQ

What was Medico Remedies Ltd.’s price range in the past 12 months?

Medico Remedies Ltd. lowest stock price was ₹35.00 and its highest was ₹62.00 in the past 12 months.

What is Medico Remedies Ltd.’s market cap?

Medico Remedies Ltd.’s market cap is ₹3.25B.

When is Medico Remedies Ltd.’s upcoming earnings report date?

Medico Remedies Ltd.’s upcoming earnings report date is May 30, 2026 which is in 73 days.

How were Medico Remedies Ltd.’s earnings last quarter?

Medico Remedies Ltd. released its earnings results on Feb 12, 2026. The company reported ₹0.346 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.346.

Is Medico Remedies Ltd. overvalued?

According to Wall Street analysts Medico Remedies Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Medico Remedies Ltd. pay dividends?

Medico Remedies Ltd. does not currently pay dividends.

What is Medico Remedies Ltd.’s EPS estimate?

Medico Remedies Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Medico Remedies Ltd. have?

Medico Remedies Ltd. has 82,984,000 shares outstanding.

What happened to Medico Remedies Ltd.’s price movement after its last earnings report?

Medico Remedies Ltd. reported an EPS of ₹0.346 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.509%.

Which hedge fund is a major shareholder of Medico Remedies Ltd.?

Currently, no hedge funds are holding shares in IN:MEDICO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medico Remedies Ltd.

Medico Remedies Limited manufactures and sells allopathic pharmaceutical preparations in India. The company offers antibiotics and anti-infective drugs; beta-lactams, and penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, and anti-epileptics and antipsychotics products; antimalarial medicines; dry syrups; ointments and creams; anti-diabetics products; and syrups. It also exports its products to Kazakhstan, Kyrgyzstan, Botswana, Jamaica, and Niger. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.